NCT03408938

Brief Summary

The principle aim of this study is to detect the accurracy of Masimo Radical-7¿ Pulse CO-Oximeter in relation to laboratory hemoglobin and estimated blood loss in intraoperative blood transfusion practice during obstetric procedures with high risk of bleeding.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 23, 2017

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2017

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

December 29, 2017

Completed
26 days until next milestone

First Posted

Study publicly available on registry

January 24, 2018

Completed
Last Updated

March 29, 2018

Status Verified

March 1, 2018

Enrollment Period

1.7 years

First QC Date

December 29, 2017

Last Update Submit

March 28, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Transfusion improvement

    Improvement of transfusion practice by detecting the amount of transfused units of RBCs during rapid blood loss

    24 hours

Secondary Outcomes (1)

  • Agreement between SpHb and laboratory Hb values

    24 hours

Study Arms (1)

Continuous Hb monitoring with Masimo Radical

Plethysmography Variability Index (PVI) is a measure of the dynamic changes in the perfusion index (PI) that occur during the respiratory cycle . PVI = ﴾PI Max - PI Min﴿ ÷ PI Maxx 100 %. PVI has the potential to provide useful information concerning changes in the balance between intrathoracic airway pressure and intravascular fluid volume. Trending of PVI may be useful in monitoring surgical patients, both intraoperatively and postoperatively, for appropriate hydration states. For example, a rising PVI may indicate developing hypovolemia and gives an alarm for the need of appropriate fluid and or blood products transfusion supported by the patient hemoglobin level

Device: of Masimo Radical-7¿ Pulse CO-Oximeter

Interventions

The Masimo pulse oximetry model: The pulse oximetry model which Masimo developed accounts for saturation values contributed by the true arterial signal, and by one or more motion or noise signals. lt is assumed that under conditions of motion, the detected IR and RD signals comprise both the true arterial saturation signal and a venous (or non-arterial) motion noise signal. Masimo uses a highly sophisticated adaptive filter with, Discrete saturation transform (DST) four other parallel engines, to leverage each algorithm's unique strengths to ensure accurate readings through all patient conditions. Masimo SET's most powerful algorithm is Signal extraction technology (SET). All algorithms depend upon assumptions. The more assumptions, the weaker the algorithm. DST makes only one assumption -that arterial blood has a higher oxygenation than venous - making it the most powerful pulse oximetry algorithm

Also known as: Puls Oximeter
Continuous Hb monitoring with Masimo Radical

Eligibility Criteria

Age16 Years - 44 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Basic subject demographics summary of age, weight, height, patient position, basal lab Hb, and start time of ADC. Basic summary of number of patients, estimated blood loss, transfusions, fluids given, mean arterial blood pressure, central venous pressure, fomites number and urine output.

You may qualify if:

  • All adult high risk patients (ASA 1-2)
  • Age group (16-44 years old)
  • Obtetric surgery with high risk of bleeding in early and late pregnancy e.g Disturbed ectopic pregnancy ,Vesicular mole , Abortion , Placenta accrete , Rupture uterus and placenta previa

You may not qualify if:

  • Significant liver disease defined as (serum alanine aminotransferase and serum aspartate aminotransferase \>2.5 times normal).
  • Significant renal disease defined as (serum creatinine \>1.5 mg/dl or creatinine clearance \<40 ml/min).
  • Significant coagulopathy defined as (INR \>1.5).
  • Use of antiplatlets or anticoagulants.
  • Anemic patients with Hb% less than 8 gm/dl

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed Abdalla Mohamed

Cairo, 11451, Egypt

Location

Study Officials

  • Ashraf Abdelmawgood, M.D

    Professor of Anesthesia&I.C.U and Pain Clinic

    STUDY CHAIR
  • Hossam El Din Mostafa, M.S

    Assistant Lecturer of Anesthesia&I.C.U and Pain Clinic

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Anesthesia&I.C.U and Pain Clinic

Study Record Dates

First Submitted

December 29, 2017

First Posted

January 24, 2018

Study Start

April 11, 2016

Primary Completion

December 23, 2017

Study Completion

December 28, 2017

Last Updated

March 29, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share

Via scholar Gate

Locations